Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

Bullboard (TSXV:TLT)

View:
Comment by Infinityon Nov 15, 2024 9:46pm

RE:RE:RE:RJFK Jr will love our company

IMO,  Secretary of health makes the Policy decisions on using the Health budget wisely to stretch the reach to more people more efficiently at lower costs.  They do not run the FDA nor does ...more  
Comment by Longholder99on Nov 15, 2024 8:12pm

RE:RE:RJFK Jr will love our company

I see us progressing to market with an FDA approval for BTD upcoming well before January.  That said, if I was backing some immuno-franken drug that works on 20% of the people 40% of the time ...more  
Comment by skier59on Nov 15, 2024 7:02pm

RE:RJFK Jr will love our company

This actually couldn't come at a worst time for us. I see more delays unfortunately.
Comment by Habeneropieon Nov 15, 2024 5:08pm

RE:RJFK Jr will love our company

Lets hope he loves TLT i doubt its on his radar. He is more focused on random wild animalls that might run over in his car and take home!   LOL Lets hope
Post by Sosak1on Nov 15, 2024 5:00pm

RJFK Jr will love our company

RFK Jr vow to purge FDA sets up collision with Big Pharma https://www.reuters.com/business/healthcare-pharmaceuticals/rfk-jr-vow-purge-fda-sets-up-collision-with-big-pharma-2024-11-15/
Comment by wearethebeston Nov 15, 2024 4:28pm

RE:RE:RE:RE:RE:RE:PP news !

One of these  days it will and I think that will be sooner  than later.  GL
Comment by rollthedice10on Nov 15, 2024 3:54pm

RE:RE:RE:RE:RE:PP news !

It IS scary, This is an example of why TLT needs to JV with someone to explore other cancer treatment markets as well. TLT simply doesn't have the resources to go it alone. I hope they are ...more  
Comment by StevenBirchon Nov 15, 2024 3:05pm

RE:RE:RE:RE:RE:PP news !

Today would be a good day to run it up late in the day ahead of the weekend.
Comment by DeathXray33on Nov 15, 2024 2:49pm

RE:RE:RE:RE:PP news !

Scary !!! What is happening? ------------------------------------------------------------- "Colorectal cancer incidence has steadily increased among younger people in the U.S. over the last two ...more  
Comment by menoalittleon Nov 15, 2024 2:38pm

RE:RE:RE:PP news !

A nice medium sized position... lol.   I'm also inclined towards topping off the tank today (excluding for the amount waiting to smack it after the right news hits... which is feeling ...more  
Post by toade1313on Nov 15, 2024 1:54pm

USA Conversion to Roth IRA

I've mentioned before but worth repeating. BEFORE TLTFF takes off, do a Roth conversion from a regular IRA. You pay tax on the amount concerted but any future gains are TAX FREE. Tax not due til ...more  
Comment by made2laston Nov 15, 2024 1:17pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:That flag formation is still looking good----

Hi all; In the USA we are blessed with a base long term capital gains tax rate of up to 20.0% plus a NIIT from our old Obamacare legislation of 3.8% surtax for certain income levels, for a total ...more  
Comment by CAinPlapon Nov 15, 2024 12:39pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:That flag formation is still looking good----

If US capital gain inclusion rate is 100%, you would have to ~ double the US rates to get a real comparison to Canadian tax rates.
Comment by Oilminerdeluxeon Nov 15, 2024 11:33am

RE:RE:RE:PP news !

Quite a handsome load of shares, DeathXray33. I can say that I am very envious. But i guess I can live with it if we hit $5-10, or more, one day.
Post by Drambueyon Nov 15, 2024 10:56am

My thoughts

Here we wait broken hearted paid for stock, monies departed  one more week, nothings started  BTD only days away (lol) but FDA has not been PAID tried phoning GATES to pave the way  but ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250